NL-OMON50024
Completed
Not Applicable
Sub(acute) Neuropsychopharmacological Profiling of 2C-B vs Psilocybin - Sub(acute) Profiling of 2C-B vs Psilocybin
Overview
- Phase
- Not Applicable
- Intervention
- Not specified
- Conditions
- drug effects, drug metabolites
- Sponsor
- niversiteit Maastricht
- Enrollment
- 24
- Status
- Completed
- Last Updated
- 2 years ago
Overview
Brief Summary
No summary available.
Investigators
Eligibility Criteria
Inclusion Criteria
- •Previous experience with at least one psychedelic substance (e.g.,
- •psilocybin, LSD, DMT, ayahuasca, psilocybe fungi \>\=1 times) but not within the
- •past three months
- •Aged between 18 and 40 years
- •Free from medication (any drug prescribed for a medical indication)
- •The participant is, in the opinion of the investigator, generally healthy
- •based on assessment of medical history, physical examination, vital signs,
- •electrocardiogram (ECG), and the results of the haematology, clinical
- •chemistry, urinalysis, serology, and other laboratory tests
- •A resting pulse and heart rate (as read on the ECG) \>\=51 bpm and \<\=100 bpm. For
Exclusion Criteria
- •Previous experience of serious side effects to psychedelic drugs (anxiety or
- •panic attacks)
- •Use of medication (other than paracetamol)
- •History of drug addiction (determined by the medical questionnaire, drug
- •questionnaire and medical examination)
- •Excessive alcohol consumption (\>20 units a week)
- •Excessive smoking (\>20 cigarettes a week)
- •Current or history of psychiatric disorder (determined by the medical
- •questionnaire and medical examination)
- •Hypertension (diastolic \>90; systolic \>140\)
Outcomes
Primary Outcomes
Not specified
Similar Trials
Not yet recruiting
Not Applicable
Sub(acute) Profiling of 2C-B Versus PsilocybiNL-OMON28125Maastricht University18
Active, not recruiting
Phase 3
To Study the Effect of Plant Formulation on sleep in Patients with Depression.Health Condition 1: null- Depressive symptoms with cognitive impairment, Sleep DisturbancesCTRI/2016/02/006681Interdisciplinary Institute of Indian System of Medicine University Building Fourth Floor60
Recruiting
Not Applicable
europsychiatric symptoms related to COVID-19: follow-up studyew Coronavirus Disease 2019 (COVID-19)C01.925.782.60RBR-8z7v5wcHospital das Clínicas da Faculdade de Medicina da Universidade de São Paulo (HCFMUSP)
Completed
Not Applicable
Effectiveness of Neuropsychological interventions for improving academic performancemathematics learning disabilities.Developmental disorder of scholastic skills, unspecifiedIRCT138905134510N1researcher30
Active, not recruiting
Phase 1
nderstanding the Neurobiology of Pharmacologically-induced Acute Stress on Ethical DecisionsMimic an acute stress response in humans.Therapeutic area: Psychiatry and Psychology [F] - Behavior and Behavior Mechanisms [F01]CTIS2023-508731-31-01niversitair Medisch Centrum Utrecht100